HC Wainwright Brokers Reduce Earnings Estimates for VERA
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Investment analysts at HC Wainwright decreased their Q2 2025 EPS estimates for Vera Therapeutics in a report issued on Wednesday, May 7th. HC Wainwright analyst A. He now expects that the company will earn ($0.90) per share for the quarter, down from their prior forecast of ($0.81). […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Investment analysts at HC Wainwright decreased their Q2 2025 EPS estimates for Vera Therapeutics in a report issued on Wednesday, May 7th. HC Wainwright analyst A. He now expects that the company will earn ($0.90) per share for the quarter, down from their prior forecast of ($0.81). […]
